Cannabis Cultivar Collection Across Canada and the International Markets

Segra Enters Agreement to Offer Allele’s Proven Cannabis Cultivar Collection Across Canada and the International Markets

VANCOUVER, (March 10, 2021) Segra International Corp. and Allele Genetics, a subsidiary of Catalyst BC, are pleased to announce they have entered into an exclusive agreement to distribute Allele’s collection of data-backed “Proven Cultivar” cannabis cultivars within the Canadian market and other legal international markets. Allele’s Proven Cultivars have been grown at both a commercial scale and for breeding and agronomic dataset development for over a decade by one of the most experienced operational teams in the industry, Catalyst BC, and its affiliates. Harnessing the strength of its proven Plant Tissue Culture technology, Segra will be releasing Allele cultivars on an ongoing basis as part of its Verified Clean Stock program.

Allele’s Proven Culticars have been carefully selected based on cannabinoid profile and yield, terpene profiles, and key characteristics such as maturation cycle time, high-density trichome area index (“TAI”), mold/mildew resistance and high bract-to-leaf ratios. The ongoing cultivar releases will represent abroad palate of terpene profiles yielding flavors and aromas ranging from citrus to berry and cake to gas–flavors the modern cannabis consumer desires. Amplifying Allele’s Proven Winners with the power of Segra’s tissue culture technologies will ensure consistently high-performing plants that are, as with all Segra tissue culture plants, Verified Clean Stock. Segra and Allele are confident that this offering will help producers turn better plants into better profits.

“Segra is thrilled to be partnering more closely with Allele and able to offer a portion of their data-backed collection, through tissue culture, to operators,” said Segra CEO Jamie Blundell. “Allele has developed an incredible portfolio of diverse, premium cannabis cultivars through tremendous industry expertise and experience. Partnering with top genetics consultants, like Allele Genetics, is central to Segra’s ability to continuously provide our clients with the cultivars of the future, and we are keen to showcase how top genetics, paired with the performance of tissue culture, will lead to operational optimization for Canadian LPs.”

“Today’s cannabis consumer desires potency, flavor, and aroma. Allele’s Proven Cultivars is a collective team effort to enhance and elevate the evolving consumer experience. We have spent the better part of a decade collecting critical agronomic data and consumer feedback necessary to drive cannabis cultivar identification, selection, collection, trialing, and optimization.” Said Eric Forington, Director of Plant Breeding and Genetics at Allele Genetics. Our primary goal is an emphasis on both consumer experience, through consistently high-quality, high-potency, flavor and aroma-forward flower, and LP success by allowing superior genetics to do the heavy agronomic lifting. We are incredibly excited to support the distribution of our Proven Cultivars in the Canadian and legal global import/export markets through Segra’s proprietary micropropagation process and look forward to partnering with Segra to provide true-to-type, commercially viable plantlets at scale.”

To learn more about this partnership and how Segra and Allele’s Tissue Culture plantlets can improve your output and reduce risk, please contact Segra at info@segra-intl.com.
 
About Allele:
 
Allele Genetics has been redefining the boundaries of high THC, high terpene cannabis breeding for over two decades and has consistently raised the bar for Top-Shelf cannabis genetics. Our breeding programs are focused on ultra-high cannabinoid content and selections from our award-winning genetics catalog consistently test over 30% THC. Allele Genetics combines over 20 years of traditional commercial cannabis breeding experience with the latest science and technology, including micro-propagation and molecular breeding tools, to enhance trait stability and provide genetic identification for our unique cannabis cultivars. Learn more about our team here.
 
About Segra:
 
Segra is an agriculture technology company offering plant tissue culture and DNA fingerprinting services to accelerate the advancement of the cannabis industry. The company’s proprietary technologies empower its clients to drive financial performance and mitigate risk while exploring the next frontier of optimized cultivation practices for the rapidly evolving cannabis consumer. Segra has developed industrial-scale laboratories to produce disease-free, robust, and DNA-fingerprinted cannabis plantlets for licensed producers globally. To support this vision, Segra has assembled a world-class team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance. Learn more about Segra here.
 
For Further Information:
 
Carson Otto
 
Forward-Looking Information:
 
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan,” “continue,” “expect,” “project,” “intend,” “believe,” “anticipate,” “estimate,” “may,” “will,” “potential,” “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks, uncertainties, and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The company is under no obligation and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by applicable law.
 

Additional Resources

Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine

Testimonials and Public Relations

Latest Articles

  • Cannabis Dispensary Compliance: Training, Inventory & Profitability
    In today’s regulated cannabis market, cannabis dispensary compliance is not optional—it is the foundation of a sustainable and profitable retail business. Every dispensary, from boutique shops to multi-state operators, must follow strict dispensary regulatory compliance standards, maintain accurate cannabis inventory management systems, and invest in ongoing cannabis dispensary training programs.
  • The Indispensable Owner’s Rep for Cannabis Cultivation Facility Buildout: Expert Project Management to Prevent Cost Overruns
    In this high-stakes arena, the Owner’s Rep for Cannabis Cultivation Facility buildout is the crucial strategic partner. They are the expert professional who ensures the owner’s vision is translated into a successful, operational, and profitable reality.
  • Cannabis Business Startup Commissioning Essential Steps and Best Practices
    The journey from concept to operation is challenging and complex in the cannabis industry. One critical phase that determines the success of a cannabis business is Cannabis Business Startup Commissioning. This process, also known as the cannabis business launch process or cannabis business commissioning, ensures that every system and operation within your facility is designed, installed, tested, and ready for full-scale production.
  • The Fiduciary Mandate: Why an Owner’s Rep is the Key to 2026 Cannabis Retail Success
    In the cannabis retail landscape of 2026, the era of “opening at any cost” has ended. As capital markets remain disciplined and consumer margins tighten, the difference between a profitable dispensary and a “zombie project” is determined during the buildout phase.
  • Open a Cannabis Consumption Lounge in New Jersey: 2026 Guide to Compliance and Success
    As of April 2026, the New Jersey cannabis market has matured into a sophisticated $4 billion powerhouse. The initial “novelty” phase has passed, and the industry is now defined by “Hospitality 2.0,” where consumption areas are becoming social anchors for local tourism in hubs like Atlantic City, Newark, and Jersey City.
  • New York Cannabis Lounge License: Expert Guide to Compliance and Success
    The New York cannabis industry has transitioned from a volatile implementation phase into a “Pharma-Grade” era of structural maturity. As of April 2026, the state has reached a monumental economic milestone, with total reported retail sales officially surpassing $3,000,000,000. For entrepreneurs, the current frontier is the “social hospitality” sector, which is defined by high-stakes technical compliance and rigorous municipal negotiation.

Explore Our Articles

cannabis applications Cannabis Bar Cannabis Business Optmization cannabis careers Cannabis Compliance Cannabis Consumption Cannabis Consumption Bar Cannabis Inventory Management Systems Cannabis Investors cannabis jobs Cannabis Legalization cannabis licensing Cannabis Lounge cannabis marketing Cannabis Operational Procedures cannabis outreach Cannabis Regulations Cannabis Security Cannabis Software Cannabis Startup Cannabis Supply Chain Cannabis Technology Colorado controlled environment agriculture Cultivation cultivation facility Dispensary Design facility design Financial Planning HVAC HVACD Iowa Kansas Legal Update Legislation Medical Cannabis Minnesota Natural Medicine Nebraska New York Odor Control Oregon Psilocybin Psychedelics Recreational Cannabis

Scroll to Top